Abnormal DNA methylation, epigenetics, and prostate cancer.
about
Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targetsDNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cellsCancer diagnostic classifiers based on quantitative DNA methylationNrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP miceEpigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cellsLoss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.Influence of oncogenic transcription factors on chromatin conformation and implications in prostate cancer.Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer.A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancerMolecular genetics of prostate cancer: new prospects for old challengesDNA methylation gene-based models indicating independent poor outcome in prostate cancer.Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene.Histone modifications and chromatin organization in prostate cancerEpigenetics in prostate cancer.Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer.DNA methylation changes in prostate cancer: current developments and future clinical implementation.Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesisGenome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanismsGenetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs.Epigenetic regulation of hepatic stellate cell activation.Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.Methylation of the RARB gene increases prostate cancer risk in black AmericansSelenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cellsGreen tea and prostate cancer: from bench to clinic.The role of histone deacetylases in prostate cancer.Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression.Molecular targets for radiation oncology in prostate cancer.The epigenetic potentials of dietary polyphenols in prostate cancer management.New concepts concerning prostate cancer screening.Prognostic DNA methylation markers for prostate cancer.A computational bioinformatics analysis of gene expression identifies candidate agents for prostate cancer.Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β.Deregulation of an imprinted gene network in prostate cancer.Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis.Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth.Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.
P2860
Q24629083-DD57586B-BEBC-4EB7-B29A-C0F2F1263F50Q24644027-4DA8D43B-9F07-4A09-8C87-B44B88B6AE86Q27012960-89F53383-935D-44D3-86E4-FFA7CCA9A14BQ33523039-6165C70E-AAC3-44C8-993F-2B750FB3F19DQ33559964-4D7D49C1-8140-484E-B2E7-57EA61CFB943Q33652512-67214F2C-816E-4EBE-9F58-CE0AB8E357B8Q33675577-3A383053-4DDB-43FC-BD9E-788FF173E9A9Q33915416-DEE717D3-0FFD-4DEB-8B1E-4364820F444BQ34091420-50411C41-5D48-458A-AFBB-ED20CAC1D71DQ34127462-A557534B-A5E4-4A17-801C-88FF99C22D99Q34174356-33090BC0-5208-4B57-823F-2A0E895AB034Q34438700-40707050-5326-4D80-BAD0-902C8E2F418EQ34559303-6BFCDE76-ED7F-47D6-B924-F0057A6E3876Q35608952-24EE7AE8-1D33-4C11-AB80-7EA52BC6B7CAQ35615797-A2C5D9E8-593B-4846-A8EC-04B5016F64DFQ35636543-8F4688DB-4CC7-4A09-9D5F-1296FDB69137Q35820533-9B91A527-D4DE-45BD-9025-386DAA7708F9Q36030914-CD227334-CC14-4FD9-9797-EDA3D598DBC7Q36213162-B8365A2F-ACF9-4EDB-924D-DE419C58C0F3Q36485297-6CB3ABAC-1928-48FC-9EB7-555615ED0BA1Q37045820-671DE647-E0AF-49EC-A73A-26E6707E481BQ37108842-768CB280-ECD5-4C81-A97C-8E110A2A6264Q37139054-BCC09BBD-B7BD-433B-85DB-FFADB164CAFEQ37187963-6AA2B6E1-26FD-400B-87EB-7A76E48DA197Q37294669-C6E5F5C3-50E7-4646-B050-2BDC5DC145C9Q37308282-055600A6-83FD-4CD7-B333-79D412D321C4Q37333510-3C1EA7D6-A232-4224-856E-06A92D923D42Q37702055-3A3C4EE6-9D0E-4800-B1E3-47B3C6212326Q38014447-8D0B5B92-0664-4A87-923C-33C861BB7C67Q38161941-191BB061-0A3A-442D-BBD7-CD13025F4757Q38220183-6DE1F4DF-4DD4-4BA4-9DEC-FF46E13F4581Q38252624-A1550E7C-8A50-40F9-BDCD-2237169E4F32Q38488799-BC5CD0BE-242C-4764-8B6E-0538869322ACQ38721818-7919C10D-9494-4891-BDE0-1045E4865296Q38817309-43FF6186-F61A-4E2E-BACC-C57CDD3294EFQ39025282-86BB9696-2054-46C1-8A39-81FF62880D5BQ39118557-15027235-5DB8-4DE9-98CE-2CC2BD631329Q39568910-71A98FAB-7074-4F26-8DE0-B71633A6F92DQ39660971-0E7C4586-218D-42A6-BC15-E5124F2B15ADQ39783504-4CB0F0E6-EEB1-4874-A4D0-9522AD9FED0B
P2860
Abnormal DNA methylation, epigenetics, and prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Abnormal DNA methylation, epigenetics, and prostate cancer.
@ast
Abnormal DNA methylation, epigenetics, and prostate cancer.
@en
type
label
Abnormal DNA methylation, epigenetics, and prostate cancer.
@ast
Abnormal DNA methylation, epigenetics, and prostate cancer.
@en
prefLabel
Abnormal DNA methylation, epigenetics, and prostate cancer.
@ast
Abnormal DNA methylation, epigenetics, and prostate cancer.
@en
P2093
P356
P1476
Abnormal DNA methylation, epigenetics, and prostate cancer.
@en
P2093
Agoston T Agoston
Angelo M De Marzo
Byron H Lee
Masashi Nakayama
Patrick J Bastian
Srinivasan Yegnasubramanian
William G Nelson
P304
P356
10.2741/2385
P577
2007-05-01T00:00:00Z